Skip to main content

Articles

Page 279 of 335

  1. Several predisposition loci for hereditary prostate cancer (HPC) have been suggested, including HPCX1 at Xq27-q28, but due to the complex structure of the region, the susceptibility gene has not yet been identifi...

    Authors: Henna Mattila, Martin Schindler, Jarkko Isotalo, Tarja Ikonen, Mauno Vihinen, Hannu Oja, Teuvo LJ Tammela, Tiina Wahlfors and Johanna Schleutker
    Citation: BMC Cancer 2011 11:327
  2. Standard treatment for patients with disseminated germ cell tumors is combination chemotherapy with bleomycin, etoposide and cisplatin (BEP). This treatment is highly effective, but the majority of patients ex...

    Authors: Jesper F Christensen, Jesper L Andersen, Lis Adamsen, Birgitte Lindegaard, Abigail L Mackey, Rie H Nielsen, Mikael Rørth and Gedske Daugaard
    Citation: BMC Cancer 2011 11:326
  3. Oral cancer incidence is high on the Island of Puerto Rico (PR), particularly among males. As part of a larger study conducted in PR, we evaluated smoking and drinking as risk factors for oral potentially mali...

    Authors: Lin Li, Walter J Psoter, Carmen J Buxó, Augusto Elias, Lumarie Cuadrado and Douglas E Morse
    Citation: BMC Cancer 2011 11:324
  4. 5-allyl-7-gen-difluoromethoxychrysin (AFMC) is a novel synthetic analogue of chrysin that has been reported to inhibit proliferation in various cancer cell lines. Tumor necrosis factor-related apoptosis-induci...

    Authors: Zhao-Hui Xie, Mei-Fang Quan, Fei Liu, Jian-Guo Cao and Jian-Song Zhang
    Citation: BMC Cancer 2011 11:322
  5. Primary intestinal non-Hodgkin lymphoma (NHL) is a heterogeneous disease with regard to anatomic and histologic distribution. Thus, analyses focusing on primary intestinal NHL with large number of patients are...

    Authors: Seok Jin Kim, Chul Won Choi, Yeung-Chul Mun, Sung Yong Oh, Hye Jin Kang, Soon Il Lee, Jong Ho Won, Min Kyoung Kim, Jung Hye Kwon, Jin Seok Kim, Jae-Yong Kwak, Jung Mi Kwon, In Gyu Hwang, Hyo Jung Kim, Jae Hoon Lee, Sukjoong Oh…
    Citation: BMC Cancer 2011 11:321
  6. CD133 is known to be a cancer stem cell (CSC) marker. However, recent studies have revealed that CD133 is not restricted to CSC but to be expressed not only in human normal tissues but also in some cancers and...

    Authors: Linni Fan, Furong He, Hongxiang Liu, Jin Zhu, Yixiong Liu, Zhiyong Yin, Lu Wang, Ying Guo, Zhe Wang, Qingguo Yan and Gaosheng Huang
    Citation: BMC Cancer 2011 11:320
  7. Currently, there are no standard guidelines for recommending re-administration of a chemotherapeutic drug to a patient after a serious adverse drug reaction (ADR) incident. The decision on whether to rechallen...

    Authors: Pei Yi Loke, Lita Chew and Chun Wei Yap
    Citation: BMC Cancer 2011 11:319
  8. MANTICORE 101 - Breast (Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research) is a randomized trial to determine if conventional heart failure pharmacotherapy (angiotensin converting e...

    Authors: Edith Pituskin, Mark Haykowsky, John R Mackey, Richard B Thompson, Justin Ezekowitz, Sheri Koshman, Gavin Oudit, Kelvin Chow, Joseph J Pagano and Ian Paterson
    Citation: BMC Cancer 2011 11:318
  9. Prostate cancer is the most common male cancer in developed countries and diagnosis and treatment carries with it substantial morbidity and related unmet supportive care needs. These difficulties may be amplif...

    Authors: Suzanne K Chambers, Robert U Newton, Afaf Girgis, Lisa Nielsen, Stephen Lepore, Cathrine Mihalopoulos, RA Gardiner, Daniel A Galvão and Stefano Occhipinti
    Citation: BMC Cancer 2011 11:317
  10. Patients with cancer have an increased risk of VTE. We compared VTE rates and bleeding complications in 1) cancer patients receiving LMWH or UFH and 2) patients with or without cancer.

    Authors: Sylvia Haas, Sebastian M Schellong, Ulrich Tebbe, Horst-Eberhard Gerlach, Rupert Bauersachs, Nima Melzer, Claudia Abletshauser, Christian Sieder, Peter Bramlage and Hanno Riess
    Citation: BMC Cancer 2011 11:316
  11. Even in the presence of oxygen, malignant cells often highly depend on glycolysis for energy generation, a phenomenon known as the Warburg effect. One strategy targeting this metabolic phenotype is glucose res...

    Authors: Gabriele D Maurer, Daniel P Brucker, Oliver Bähr, Patrick N Harter, Elke Hattingen, Stefan Walenta, Wolfgang Mueller-Klieser, Joachim P Steinbach and Johannes Rieger
    Citation: BMC Cancer 2011 11:315
  12. Mammographic density (MD) and malignant-appearing microcalcifications (MAMCs) represent the earliest mammographic findings of non-palpable breast carcinomas. Matrix proteoglycans versican and decorin are frequ...

    Authors: Spyros S Skandalis, Vassiliki T Labropoulou, Panagiota Ravazoula, Eleni Likaki-Karatza, Katalin Dobra, Haralabos P Kalofonos, Nikos K Karamanos and Achilleas D Theocharis
    Citation: BMC Cancer 2011 11:314
  13. This phase 1b study assessed the maximum tolerated dose (MTD), safety, and pharmacokinetics of motesanib (a small-molecule antagonist of VEGF receptors 1, 2, and 3; platelet-derived growth factor receptor; and...

    Authors: Dusan Kotasek, Niall Tebbutt, Jayesh Desai, Stephen Welch, Lillian L Siu, Sheryl McCoy, Yu-Nien Sun, Jessica Johnson, Adeboye H Adewoye and Timothy Price
    Citation: BMC Cancer 2011 11:313
  14. Monocarboxylate transporters (MCTs) are transmembrane proteins involved in the transport of monocarboxylates across the plasma membrane, which appear to play an important role in solid tumours, however the rol...

    Authors: Nelma Pértega-Gomes, José R Vizcaíno, Vera Miranda-Gonçalves, Céline Pinheiro, Joana Silva, Helena Pereira, Pedro Monteiro, Rui M Henrique, Rui M Reis, Carlos Lopes and Fátima Baltazar
    Citation: BMC Cancer 2011 11:312
  15. Strategies for cancer reduction and management are targeted at both individual and area levels. Area-level strategies require careful understanding of geographic differences in cancer incidence, in particular ...

    Authors: Susanna M Cramb, Kerrie L Mengersen and Peter D Baade
    Citation: BMC Cancer 2011 11:311
  16. Open transthoracic oesophagectomy is the standard treatment for infracarinal resectable oesophageal carcinomas, although it is associated with high mortality and morbidity rates of 2 to 10% and 30 to 50%, resp...

    Authors: Nicolas Briez, Guillaume Piessen, Franck Bonnetain, Cécile Brigand, Nicolas Carrere, Denis Collet, Christophe Doddoli, Renaud Flamein, Jean-Yves Mabrut, Bernard Meunier, Simon Msika, Thierry Perniceni, Frédérique Peschaud, Michel Prudhomme, Jean-Pierre Triboulet and Christophe Mariette
    Citation: BMC Cancer 2011 11:310
  17. E7080 is an orally active multi-targeted kinase inhibitor whose targets include vascular endothelial growth factor receptors (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor...

    Authors: Hilary Glen, Susan Mason, Hitesh Patel, Kenneth Macleod and Valerie G Brunton
    Citation: BMC Cancer 2011 11:309
  18. Ovarian cancer is the most deadly gynecological cancer with a very poor prognosis. Xenograft mouse models have proven to be one very useful tool in testing candidate therapeutic agents and gene function in vivo. ...

    Authors: Ashley Stuckey, Andrew Fischer, Daniel H Miller, Sara Hillenmeyer, Kyu K Kim, Anna Ritz, Rakesh K Singh, Benjamin J Raphael, Laurent Brard and Alexander S Brodsky
    Citation: BMC Cancer 2011 11:308
  19. Polysaccharides extracted from the Phellinus linteus (PL) mushroom are known to possess anti-tumor effects. However, the molecular mechanisms responsible for the anti-tumor properties of PL remain to be explored....

    Authors: Kyoung-Sub Song, Ge Li, Jong-Seok Kim, Kaipeng Jing, Tae-Dong Kim, Jin-Pyo Kim, Seung-Bo Seo, Jae-Kuk Yoo, Hae-Duck Park, Byung-Doo Hwang, Kyu Lim and Wan-Hee Yoon
    Citation: BMC Cancer 2011 11:307
  20. MUTYH-associated polyposis (MAP) is an autosomal recessive form of intestinal polyposis predisposing to colorectal carcinoma. High resolution melting analysis (HRMA) is a mutation scanning method that allows det...

    Authors: Rossella Tricarico, Francesca Crucianelli, Antonio Alvau, Claudio Orlando, Roberta Sestini, Francesco Tonelli, Rosa Valanzano and Maurizio Genuardi
    Citation: BMC Cancer 2011 11:305
  21. Breast cancer is the second leading cause of cancer-related death in women in the United States. During the advanced stages of disease, many breast cancer patients suffer from bone metastasis. These metastases...

    Authors: Anguraj Sadanandam, Mitsuru Futakuchi, Costas A Lyssiotis, William J Gibb and Rakesh K Singh
    Citation: BMC Cancer 2011 11:304
  22. Leptin is a pleiotropic hormone whose mitogenic and angiogenic activity has been implicated in the development and progression of several malignancies, including brain tumors. In human brain cancer, especially...

    Authors: Rita Ferla, Maria Bonomi, Laszlo Otvos Jr and Eva Surmacz
    Citation: BMC Cancer 2011 11:303
  23. Fatty acid binding proteins (FABP) play an important role in carcinogenesis. Modified FABP expression patterns were described for prostate, bladder and for renal cell carcinoma. Studies on metabolic relationsh...

    Authors: Angelika Tölle, Saba Suhail, Monika Jung, Klaus Jung and Carsten Stephan
    Citation: BMC Cancer 2011 11:302
  24. Multiple myeloma is an incurable disease requiring the development of effective therapies which can be used clinically. We have elucidated the potential for manipulating the cAMP signaling pathway as a target ...

    Authors: Virginie Follin-Arbelet, Peter O Hofgaard, Harald Hauglin, Soheil Naderi, Anders Sundan, Rune Blomhoff, Bjarne Bogen and Heidi K Blomhoff
    Citation: BMC Cancer 2011 11:301
  25. Emmprin, a glycoprotein containing two Ig domains, is enriched on tumor cell surfaces and stimulates matrix metalloproteinase (MMP) production by adjacent stromal cells. Its first Ig domain (ECI) contains the ...

    Authors: Takehito Kawakami, Tetsuro Sameshima, Hironobu Hojo, Kaori Koga, Yoshiaki Nakahara, Bryan P Toole, Junji Suzumiya, Yasunori Okada, Akinori Iwasaki and Kazuki Nabeshima
    Citation: BMC Cancer 2011 11:300
  26. A breast cancer prognostic tool should ideally be applicable to all types of invasive breast lesions. A number of studies have shown histopathological grade to be an independent prognostic factor in breast can...

    Authors: André Albergaria, Sara Ricardo, Fernanda Milanezi, Vítor Carneiro, Isabel Amendoeira, Daniella Vieira, Jorge Cameselle-Teijeiro and Fernando Schmitt
    Citation: BMC Cancer 2011 11:299
  27. Improving the coordination of cancer care is a priority area for service improvement. However, quality improvement initiatives are hindered by the lack of accurate and reliable measures of this aspect of cance...

    Authors: Jane M Young, Jennifer Walsh, Phyllis N Butow, Michael J Solomon and Joanne Shaw
    Citation: BMC Cancer 2011 11:298
  28. Since transitional cell carcinoma (TCC) of the upper urinary tract is a relatively uncommon malignancy, the role of adjuvant radiotherapy is unknown.

    Authors: Bing Chen, Zhao-Chong Zeng, Guo-Min Wang, Li Zhang, Zong-Ming Lin, Li-An Sun, Tong-Yu Zhu, Li-Li Wu, Jian-Ying Zhang and Yuan Ji
    Citation: BMC Cancer 2011 11:297
  29. Systemic therapy for cancer metastatic lesions is difficult and generally renders a poor clinical response. Structural analogs of cisplatin, the most widely used synthetic metal complexes, show toxic side-effe...

    Authors: Fabiana A Serrano, Alisson L Matsuo, Priscila T Monteforte, Alexandre Bechara, Soraya S Smaili, Débora P Santana, Tiago Rodrigues, Felipe V Pereira, Luis S Silva, Joel Machado Jr, Edson L Santos, João B Pesquero, Rafael M Martins, Luiz R Travassos, Antonio CF Caires and Elaine G Rodrigues
    Citation: BMC Cancer 2011 11:296
  30. Data on sequential therapy in patients with metastatic renal cell carcinoma (mRCC) and intrinsic resistance to receptor tyrosine kinase inhibitor (rTKI) treatment remains vague.

    Authors: Jonas Busch, Christoph Seidel, Steffen Weikert, Ingmar Wolff, Carsten Kempkensteffen, Lisa Weinkauf, Stefan Hinz, Ahmed Magheli, Kurt Miller and Viktor Grünwald
    Citation: BMC Cancer 2011 11:295
  31. In ovarian cancer, the reported rate of EGFR expression varies between 4-70% depending on assessment method and data on patient outcome are conflicting. Methods: In this study we investigated EGFR expression a...

    Authors: Aurelia Noske, Michael Schwabe, Wilko Weichert, Silvia Darb-Esfahani, Ann-Christin Buckendahl, Jalid Sehouli, Elena I Braicu, Jan Budczies, Manfred Dietel and Carsten Denkert
    Citation: BMC Cancer 2011 11:294
  32. Molecular classification of breast cancer is an important prognostic factor. The distribution of molecular subtypes of breast cancer and their prognostic value has not been well documented in Asians.

    Authors: Yinghao Su, Ying Zheng, Wei Zheng, Kai Gu, Zhi Chen, Guoliang Li, Qiuyin Cai, Wei Lu and Xiao Ou Shu
    Citation: BMC Cancer 2011 11:292
  33. To evaluate the association between polymorphisms involved in DNA repair and oxidative stress genes and mean dose to whole breast on acute skin reactions (erythema) in breast cancer (BC) patients following sin...

    Authors: Elisabetta Falvo, Lidia Strigari, Gennaro Citro, Carolina Giordano, Stefano Arcangeli, Antonella Soriani, Daniela D'Alessio, Paola Muti, Giovanni Blandino, Isabella Sperduti and Paola Pinnarò
    Citation: BMC Cancer 2011 11:291
  34. CD44, a hyaluronan (HA) receptor, is a multistructural and multifunctional cell surface molecule involved in cell proliferation, cell differentiation, cell migration, angiogenesis, presentation of cytokines, c...

    Authors: Xin Jian Fang, Hua Jiang, Xv Peng Zhao and Wei Mei Jiang
    Citation: BMC Cancer 2011 11:290
  35. Platinum agents have shown demonstrable activity in the treatment of patients with platinum resistant, recurrent ovarian cancer when delivered in a "dose-dense" fashion. However, the development of thrombocyto...

    Authors: Rohini Sharma, Janet Graham, Sarah Blagden and Hani Gabra
    Citation: BMC Cancer 2011 11:289
  36. XELOX (capecitabine + oxaliplatin) and FOLFOX 4 (5-FU + folinic acid + oxaliplatin) have shown similar improvements in survival in patients with metastatic colorectal cancer (MCRC). A US cost-minimization stud...

    Authors: Vicki C Tse, Wai Tong Ng, Victor Lee, Anne WM Lee, Daniel TT Chua, June Chau and Sarah M McGhee
    Citation: BMC Cancer 2011 11:288
  37. Weight loss in overweight or obese breast cancer patients is associated with an improved prognosis for long term survival. However, it is not clear whether the macronutrient composition of the chosen weight lo...

    Authors: Scot M Sedlacek, Mary C Playdon, Pamela Wolfe, John N McGinley, Mark R Wisthoff, Elizabeth A Daeninck, Weiqin Jiang, Zongjian Zhu and Henry J Thompson
    Citation: BMC Cancer 2011 11:287
  38. The utility of circulating angiogenic cytokines (CAC) as biomarkers in pancreatic cancer has not been clarified yet. We investigated the expression and prognostic associations of seven CAC in patients with pan...

    Authors: Nuh N Rahbari, Thomas Schmidt, Christine S Falk, Ulf Hinz, Magdalene Herber, Ulrich Bork, Markus W Büchler, Jürgen Weitz and Moritz Koch
    Citation: BMC Cancer 2011 11:286
  39. Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to endothelial cells. It requires interactions between adhesion receptors ...

    Authors: Nicolas Porquet, Andrée Poirier, François Houle, Anne-Laure Pin, Stéphanie Gout, Pierre-Luc Tremblay, Éric R Paquet, Roscoe Klinck, François A Auger and Jacques Huot
    Citation: BMC Cancer 2011 11:285
  40. Adherence to pharmacological therapy is a complex and multi-factorial issue that can substantially alter the outcome of treatment. It has been shown that cancer patients, especially when using long-term medica...

    Authors: Lonneke Timmers, Christel CLM Boons, Dirk Mangnus, Josee E Moes, Eleonora L Swart, Epie Boven, Egbert F Smit and Jacqueline G Hugtenburg
    Citation: BMC Cancer 2011 11:284
  41. Using a longitudinal design, aim of this study was to investigate the relation between mental adjustment to cancer and anxiety, depression, health-related quality of life (HRQL) and survival in patients treate...

    Authors: Mia Johansson, Anna Rydén and Caterina Finizia
    Citation: BMC Cancer 2011 11:283
  42. France stands among high-risk areas for colorectal cancer. Different trends in CRC incidence are reported around the world. The aim of this study was to provide temporal trends in CRC incidence over a 30-year ...

    Authors: Marion Chauvenet, Vanessa Cottet, Côme Lepage, Valérie Jooste, Jean Faivre and Anne-Marie Bouvier
    Citation: BMC Cancer 2011 11:282
  43. Obesity and related metabolic abnormalities, including inflammation and lipid accumulation in the liver, play a role in liver carcinogenesis. Adipocytokine imbalances, such as decreased serum adiponectin level...

    Authors: Masahito Shimizu, Yoichi Yasuda, Hiroyasu Sakai, Masaya Kubota, Daishi Terakura, Atsushi Baba, Tomohiko Ohno, Takahiro Kochi, Hisashi Tsurumi, Takuji Tanaka and Hisataka Moriwaki
    Citation: BMC Cancer 2011 11:281
  44. Since a substantial percentage of ovarian cancers express gonadotropin receptors and are responsive to the relatively high concentrations of pituitary gonadotropins during the postmenopausal years, it has been...

    Authors: Juan Cui, Brooke M Miner, Joanna B Eldredge, Susanne W Warrenfeltz, Phuongan Dam, Ying Xu and David Puett
    Citation: BMC Cancer 2011 11:280
  45. After primary treatment for breast cancer, patients are recommended to use hospital follow-up care routinely. Long-term data on the utilization of this follow-up care are relatively rare.

    Authors: Wenli Lu, Liesbeth Jansen, Michael Schaapveld, Peter C Baas, Theo Wiggers and Geertruida H De Bock
    Citation: BMC Cancer 2011 11:279

Featured videos

View featured videos from across the BMC-series journals